Transcriptional control of osteoblast growth and differentiation

Physiological Reviews

Volumn 76, Issue 2, 1996, Pages 593-629

  Stein, Gary S ^a   Lian, Jane B ^a   Stein, Janet L ^a   Van Wijnen, André J ^a   Montecino, Martin ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; CELL DIFFERENTIATION; CELL GROWTH; HUMAN; HUMAN CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0029978629     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1996.76.2.593     Document Type: Review

References (461)

1. ABULAFIA, R., A. BEN-ZE'EV, N. ILAY, AND Y. ALONI. Control of late SV40 transcription by the attenuation mechanism and transcriptionally active ternary complexes are associated with the nuclear matrix. J. Mol. Biol. 172: 467-487, 1984.
2. ANDRIANARIVO, A. G., J. A. ROBINSON, K. G. MANN, AND R. P. TRACY. Growth on type I collagen promotes expression of the osteoblast phenotype in human osteosarcoma MG-63 cells. J. Cell. Physiol. 153, 256-265, 1992.
3. 3. Toxicol. Appl. Pharmacol. 103: 113-120, 1990.
4. ANTOSZ, M. E., C. G. BELLOWS, AND J. E. AUBIN. Effects of transforming growth factor β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells. J. Cell. Physiol. 140: 386-395, 1989.
5. 3. Mol. Endocrinol. 7: 1307-1312, 1993.
6. ARONOW, M. A., L. C. GERSTENFELD, T. A. OWEN, M. S. TASSINARI, G. S. STEIN, AND J. B. LIAN. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J. Cell. Physiol. 143: 213-221, 1990.
7. ASHTON, B. A., C. C. EAGLESON, I. BAB, AND M. E. OWEN. Distribution of fibroblastic colony-forming cells in rabbit bone marrow and assay of their osteogenic potential by an in vivo diffusion chamber method. Calcif. Tissue Int. 36: 83-86, 1984.
8. ASLAM, F., J. B. LIAN, G. S. STEIN, J. L. STEIN, G. LITWACK, A. J. VAN WIJNEN, AND V. SHALHOUB. Glucocorticoid responsiveness of the osteocalcin gene by multiple distal and proximal elements (Abstract). J. Bone Miner. Res. 9: S125, 1994.
9. ASLAM, F , V. SHALHOUB, A. J. VAN WIJNEN, C. BANERJEE, R. BORTELL, A. R. SHAKOORI, G. LITWACK, J. L. STEIN, G. S. STEIN, AND J. B. LIAN. Contributions of distal and proximal promoter elements to glucocorticoid regulation of osteocalcin gene transcription. Mol. Endocrinol. 9: 679-690, 1995.
10. ATCHISON, M. L., O. MEYUHAS, AND R. P. PERRY. Localization of transcriptional regulatory elements and nuclear factor binding sites in mouse ribosomal protein gene rpL32. Mol. Cell. Biol. 9: 2067-2074, 1989.
11. AUBIN, J. E., J. N. M. HEERSCHE, M. J. MERRILESS, AND J. SODEK. Isolation of bone cell clones with differences in growth, hormone responses and extracellular matrix production. J. Cell Biol. 92: 452-461, 1982.
12. AUBIN, J. E., K. TURKSEN, AND J. N. M. HEERSCHE. Osteoblastic cell lineage. In: Cellular and Molecular Biology of Bone, edited by M. Noda. New York: Academic, 1993, p. 1-45.
13. BAKER, A. R., P. G. HOLLINGSHEAD, S PITTS-MEEK, S. HANSEN, R. TAYLOR, AND T. A STEWART. Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice. Mol. Cell. Biol. 12: 5541-5547, 1992.
14. BANERJEE, C., J. L. STEIN, A. J. VAN WIJNEN, B. FRENKEL, J. B. LIAN, AND G. S. STEIN. TGF-β1 responsiveness of the rat osteocalcin gene is mediated by an AP-1 binding site. Endocrinology. In press.
15. BANERJEE, C., J. L. STEIN, J. B. LIAN, AND G. S. STEIN. A PEBP2/ AML-related protein is essential for basal and enhanced expression of the rat osteocalcin gene during osteoblast differentiation. Proc. Natl. Acad. Sci. USA In press.
16. BANIAHMAD, A., M. MULLER, C. STEINER, AND R. RENKAWITZ. Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J. 6: 2297-2303, 1987.
17. BANIAHMAD, A, C. STEINER, A. C. KOHNE, AND R. RENKAWITZ. Modular structure of a chicken lysozyme silencer involvement of an unusual thyroid hormone receptor binding site. Cell 61: 505-514, 1990.
18. BANIAHMAD, A., S. Y. TSAI, B. W. O'MALLEY, AND M.-J. TSAI. Kindred S thyroid hormone receptor is an active and constitutive silencer and a represser for thyroid hormone and retinoic acid responses. Proc. Natl. Acad. Sci. USA 89: 10633-10637, 1992.
19. BARAN, D. T., A. M. SORENSEN, T. OWEN, V. SHALHOUB, G. S. STEIN, AND J. B. LIAN. 1α,25-Dihydroxyvitamin D, rapidly increases cytosolic calcium in clonai rat osteosarcoma cells lacking the vitamin D receptor. J. Bone Miner. Res 6: 1269-1275, 1991.
20. 3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells. J. Cell. Biochem. 50: 124-129, 1992.
21. BARONE, L. M., M. A. ARONOW, E. CANALIS, G. S. STEIN, AND J. B. LLAN. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin and matrix Gla protein, in vitro. J. Cell. Physiol. 160: 255-264, 1994.
22. BARONE, L. M., T. A. OWEN, M. S. TASSINARI, R. BORTELL, G. S. STEIN, AND J. B. LIAN. Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J. Cell. Biochem. 46: 351-365, 1991.
23. BARRACK, E. R., AND D. S. COFFEY. Hormone receptors and the nuclear matrix. In: Gene Regulation by Steroid Horinones II, edited by A. K. Roy and J. H. Clark. New York: Springer-Verlag, 1983, p. 239-266.
24. BASERGA, R., AND R. RUBIN. Cell cycle and growth control. Crit. Rev. Eukaryotic Gene Expression 3: 47-61, 1993.
25. 1. Oncogene 9: 71-79, 1994.
26. BECK, L. S., E. P. AMENTO, Y. XU, L. DEGUZMAN, W. P. LEE, T. NGUYEN, AND N. A. GILLETT. TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1. J. Bone Miner. Res. 8: 753-761, 1993.
27. BEDALOV, A, D. T. BREAULT, B. P. SOKOLOV, A. C. LICHTLER, I. BEDALOV, S. H. CLARK, K. MACK, J. S. KHILLAN, C. O. WOODY, AND B. E. KREAM. Regulation of the alpha 1 (I) collagen promoter in vascular smooth muscle cells. Comparison with other alpha 1(I) collagen-producing cells in transgenic animals and cultured cells. J. Biol. Chem. 269: 4903-4909, 1994.
28. BELGRADER, P., A. J. SIEGEL, AND R. BEREZNEY. A comprehensive study on the isolation and characterization of the HeLa S3 nuclear matrix. J. Cell Sci. 98: 281-291, 1991.
29. BELLOWS, C. G., J. E. AUBIN, AND J. N. M. HEERSCHE. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121: 1985-1992, 1987.
30. BELLOWS, C. G., J. N. M. HEERSCHE, AND J. E. AUBIN. Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev. Biol. 140: 132-138, 1990.
31. BENNETT, J. H., AND M. E. OWEN. Osteogenic differentiation of marrow stromal cells. In: The Biological Mechanisms of Tooth Movement and Craniofacial Adaptation, edited by Z. Davidovitch. Columbus, OH: Ohio State Univ. College of Dentistry, 1992, p. 91-96.
32. BENNETT, V. P., I. M. WEISS, AND S. L. ADAMS. Cartilage-specific 5′ end of chick α2(1) collagen mRNAs. J. Biol. Chem. 264: 8402-8408, 1989.
33. BEN-ZE'EV, A., AND Y. ALONI. Processing of SV40 RNA is associated with the nuclear matrix and is not followed by the accumulation of low-molecular weight RNA products. Virology 125: 475-479, 1983.
34. BEREZNEY, R., AND D. S. COFFEY. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60: 1410-1417, 1974.
35. BEREZNEY, R., AND D. S. COFFEY. Nuclear protein matrix: association with newly synthesized DNA. Science Wash. DC 189: 291-292, 1975.
36. BEREZNEY, R., AND D. S. COFFEY. Nuclear matrix: isolation and characterization of a framework structure from rat liver nuclei. J. Cell Biol. 73: 616-637, 1977.
37. BHARGAVA, U., M. BAR-LEV, C. G. BELLOWS, AND J. E. AUBIN. Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. Bone 9: 155-163, 1988.
38. BIDWELL, J. P., E. G. FEY, A. J. VAN WIJNEN, S. PENMAN, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res. 54: 28-32, 1994.
39. BIDWELL, J. P., A. J. VAN WIJNEN, C. BANERJEE, E. G. FEY, H. MERRIMAN, S. PENMAN, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. PTH-responsive modifications in the nuclear matrix of ROS 17/2.8 rat osteosarcoma cells. Endocrinology 134: 1738-1744, 1994.
40. BIDWELL, J. P , A. J. VAN WIJNEN, E. G. FEY, S. DWORETZKY, S. PENMAN, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Osteocalcin gene promoter binding factors are tissue-specific nuclear matrix components. Proc. Natl. Acad. Sci. USA 90: 3162-3166, 1993.
41. BIKLE, D. D. Clinical counterpoint. Vitamin D: new actions, new analogs, new therapeutic potential. Endocr. Rev. 13: 765-784, 1992.
42. BIRNBAUM, M. J., K. L. WRIGHT, A. J. VAN WIJNEN, A. L RAMSEY-EWING, M. T. BOURKE, T. J. LAST, F. AZIZ, B. FRENKEL, B. R. RAO, N. ARONIN, G. S. STEIN, AND J. L. STEIN. Functional role for Sp1 in the transcriptional amplification of a cell cycle regulated human histone H4 gene. Biochemistry 34: 7648-7658, 1995.
43. BLANCO, J. C. G., I.-M. WANG, S. Y. TSAI, M.-J. TSAI, B. W O'MALLEY, P. W. JURUTKA, M. R. HAUSSIER, AND K. OZATO. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA 92: 1535-1539, 1995.
44. BODE, J., AND K. MASS. Chromatin domain surrounding the human interferon-β gene as defined by scaffold-attached regions. Biochemistry 27: 4706-4711, 1988.
45. BOGDANOVIC, Z., A. BEDALOV, P. H. KHEBSBACH, D. PAVLIN, C. O. WOODY, S. H. CLARK, H. F. THOMAS, D. W. ROWE, B. E. KREAM, AND A. C. LICHTLER. Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice. J. Bone Miner. Res. 9: 285-292, 1994.
46. BONEWALD, L. F., AND S. L. DALLAS. Role of active and latent transforming growth factor β in bone formation. J. Cell. Biochem 55: 350-357, 1994.
47. BORTELL, R., T. A. OWEN, J. P. BIDWELL, P. GAVAZZO, E. BREEN, A. J. VAN WIJNEN, H. F. DELUCA, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc. Natl. Acad. Sci. USA 89: 6119-6123, 1992.
48. BORTELL, R., T. A. OWEN, V. SHALHOUB, A. HEINRICHS, M. A B. ARONOW, AND G. S. STEIN. Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements. Proc. Natl. Acad. Sci. USA 90: 2300-2304, 1993.
49. 1. J. Cell. Biochem. 50: 62-72, 1992.
50. BORUN, T. W., AND G. S. STEIN. The synthesis of acidic chromosomal proteins during the cell cycle of HeLa S3 cells. II. The kinetics of residual protein synthesis and transport. J. Cell Biol. 52: 308-315, 1972.
51. BRADLEY, D. W., Q. P. DOU, J. L. FRIDOVICH-KEIL, AND A B. PARDEE. Transformed and nontransformed cells differ in stability and cell cycle regulation of a DNA binding activity to the murine thymidine kinase promoter. Proc. Natl Acad. Sci. USA 87: 9310-9314, 1990.
52. BREEN, E. C., R. IGNOTZ, L. McCABE, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro preventing development of the mature bone phenotype. J. Cell. Physiol. 160: 323-335, 1994.
53. BREEN, E. C., A. J. VAN WIJNEN, J. B. LIAN, G. S. STEIN, AND J. L. STEIN. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D dependent transcriptional upregulation in intact cells. Proc. Natl. Acad. Sci. USA 91: 12902-12906, 1994.
54. 3 on collagen type I, osteopontin, and osteocalcin gene expression in chicken osteoblasts. J. Cell. Biochem. 57: 440-451, 1995.
55. 3 action. J. Biol. Chem. 265: 10025-10029, 1990.
56. BRUDER, S. P., AND A. I. CAPLAN. First bone formation and the dissection of the osteogenic lineage in the embryonic chick tibia is revealed by monoclonal antibodies against osteoblasts. Bone 11: 359-375, 1989.
57. BRUDER, S. P., AND A. I. CAPLAN. Discrete stages within the osteogenic lineage are revealed by alterations in the cell surface architecture of embryonic bone cells. In: Third International Conference on the Chemistry and Biology of Mineralized Tissue, edited by M. J. Glimcher and J. B. Lian. New York: Gordon & Breach, 1989, p. 73-79.
58. BRUDER, S. P., AND A. I. CAPLAN. Discrete stages within the osteogenic lineage are revealed by alterations in the cell-surface architecture of embryonic bone cells. Connect. Tissue Res. 20: 73-79, 1989.
59. BRUDER, S. P., AND A. I. CAPLAN. Terminal differentiation of osteogenic cells in the embryonic chick tibia is revealed by a monoclonal antibody against osteocytes. Bone 11: 189-198, 1990.
60. CANALIS, E., AND J. B. LIAN. Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9: 243-246, 1988.
61. CAO, S. H., P. D. GUTMAN, H. P. G. DAVE, AND A. N. SCHECHTER. Identification of a transcriptional silencer in the 5′-flanking region of the human e-globin gene. Proc. Natl. Acad. Sci. USA 86: 5306-5309, 1989.
62. CAPCO, D. G , K. M. WAN, AND S. PENMAN. The nuclear matrix: three-dimensional architecture and protein composition. Cell 29: 847-858, 1982.
63. CARLBERG, C., I. BENDIK, A. WYSS, E. MEIER, L. J. STURZENBECKER, J. F. GRIPPO, AND W. HUNZIKER. Two nuclear signalling pathways for vitamin D. Nature Lond. 361: 657-60, 1993.
64. CARLSON, C. S., H. M. TULLI, M. J. JAYO, R. F. LOESER, R. P. TRACY, K. G. MANN, AND M. R. ADAMS. Immunolocalization of noncollagenous bone matrix proteins in lumbar vertebrae from intact and surgically menopausal cynomolgus monkeys. J. Bone Miner. Res 8: 71-81, 1993.
65. CELESTE, A. J., V. ROSEN, J. L. BUECKER, R. KRIZ, E. A. WANG, AND J. M. WOZNEY. Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J. 5: 1885-1890, 1986.
66. CHENG, S. L., J. W. YANG, L. RIFAS, S. F. ZHANG, AND L. AVIOLI. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286, 1994.
67. 3 receptor (VDR) homeodimers into VDR-retinoid X receptor heterodimers. Mol. Cell Biol. 14: 3329-3338, 1994.
68. CHRYSOGELOS, S., U. PAULI, G. S. STEIN, AND J. L. STEIN. Fine mapping of the chromatin structure of a cell cycle-regulated human H4 histone gene. J. Biol Chem. 264: 1232-1237, 1989.
69. CHRYSOGELOS, S., D. E. RILEY, G. STEIN, AND J. STEIN. A human histone H4 gene exhibits cell cycle-dependent changes in chromatin structure that correlate with its expression. Proc. Natl. Acad. Sci. USA 82: 7535-7539, 1985.
70. CIEJEK, E. M., M.-J. TSAI, AND B. W. O'MALLEY. Actively transcribed genes are associated with the nuclear matrix. Nature Lond. 306: 607-609, 1983.
71. COCKERILL, P. N., AND W. T. GARRARD. Chromosomal loop anchorage of the kappa inuiiuno-globulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44: 273-282, 1986.
72. COHEN, S. M., G. BRÖNER, F. KÜTTNER, G. JÜRGENS, AND H. JACKLE. Distal-less encodes a homeodomain protein required for limb development in Drosophila. Nature Lond. 338: 432-434, 1989.
73. COLLART, D. G., A. RAMSEY-EWING, R. BORTELL, J. LIAN, J. STEIN, AND G. STEIN. Isolation and characterization of a cDNA from a human histone H2B gene which is reciprocally expressed in relation to replication-dependent H2B histone genes during HL60 cell differentiation. Biochemistry 30: 1610-1617, 1991.
74. COLLART, D. G., G. S. STEIN, AND J. L. STEIN. A series of repetitive DNA sequences are associated with human core and H1 histone genes. Mol. Cell. Biochem. 67: 161-170, 1985.
75. COLLART, D. G., K. L. WRIGHT, A. J. VAN WIJNEN, A. L. RAMSEY, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. The human H1 histone gene FNC16 is functionally expressed in proliferating HeLa S3 cells and is downregulated during terminal differentiation in HLGO cells. J. Biol. Chem. 263: 15860-15863, 1988.
76. COPPOCK, D. L., AND A. B. PARDEE. Control of thymidine kinase mRNA during the cell cycle. Mol. Cell. Biol. 1: 2925-2932, 1987.
77. DAILEY, L., S. M. HANLY, R G. ROEDER, AND N. HEINTZ. Distinct transcription factors bind specifically to two regions of the human histone H4 promoter, Proc. Natl. Acad. Sci. USA 83: 7241-7245, 1986.
78. DAILEY, L., S. B. ROBERTS, AND N. HEINTZ. Purification of the human histone H4 gene-specific transcription factors H4TF-1 and H4TF-2. Genes Dev. 2: 1700-1712, 1988.
79. DALLAS, S. L., S. PARK-SNYDER, K. MIYAZONO, D. TWARDZIK, G. R. MUNDY, AND B. L. BONEWALD. Characterization and autoregulation of latent transforming growth factor β (TGFβ) complexes in osteoblast-like cell lines: production of a latent complex lacking the latent TGFβ-binding protein (LTBP). J. Biol. Chem. 269: 6815-6821, 1994.
80. DALTON, S., AND J. R. E. WELLS. A gene-specific promoter element is required for optimal expression of the histone H1 gene in S-phase. EMBO J. 1: 49-56, 1988.
81. 3 receptor. Biochim. Biophys. Acta 1167: 29-36, 1993.
82. 3-response element in the 5′-flanking region of the rat calbindin D-9K gene. Proc. Natl. Acad Sci. USA 89: 603-607, 1992.
83. DARWISH, H. M., AND H. F. DELUCA. Vitamin D-regulated gene expression. Crit. Rev. Eukaryotic Gene Expression 3: 89-116, 1993.
84. DEFRANCO, D. J., J. B. LIAN, AND J. GLOWACKI. Differential effects of glucocorticoid on recruitment and activity of osteoclasts induced by normal and osteocalcin-deficient bone implanted in rats. Endocrinology 131: 114-121, 1992.
85. DE JONG, L., R. VAN DRIEL, N. STUURMAN, A. M. L. MEIJNE, AND J. VAN RENSWOUDE. Principles of nuclear organization. Cell Biol. Int. Rep. 14: 1051-1074, 1990.
86. DELANY, A. M., Y. DONG, AND E. CANALIS. Mechanisms of glucocorticoid action in bone cells. J. Cell. Biochem. 56: 295-302, 1994.
87. 3. Proc. Natl. Acad. Sci. USA 87: 369-373, 1990.
88. 3 receptor interactions with target sequences in the rat osteocalcin gene. Mol. Endocrinol. 6, 557-562, 1992.
89. 3. Proc. Natl. Acad. Sci. USA 89: 8097-8101, 1992.
90. DESBOIS, C., A. BRADLEY, AND G. KARSENTY. Study of osteocalcin function in mouse by targeted disruption (Abstract). J. Bone Miner. Res. 9, Suppl.: S376, 1994.
91. DESBOIS, C., D. A. HOGUE, AND G. KARSENTY. The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J. Biol. Chem. 269: 1183-1190, 1994.
92. 1/S phase. Proc. Natl. Acad. Sci. USA 88: 1157-1161, 1991.
93. 1/S event. Proc Natl. Acad. Sci. USA 80: 3256-3260, 1992.
94. DRUMMOND, I. A., S. L. MADDEN, P. ROHWER-NUTTER, G. I. BELL, V. P. SUKHATME, AND F. J. RAUSCHER III. Repression of the insulin-like growth factor II gene by the wilms tumor suppressor WT1. Science Wash. DC 257: 674-678, 1992.
95. DWORETZKY, S. I., E. G. FEY, S. PENMAN, J. B. LLAN, J. L. STEIN, AND G. S. STEIN. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc. Natl. Acad. Sci. USA 87: 4605-4609. 1990.
96. DWORETZKY, S. L. K. L. WRIGHT, E. G. FEY, S. PENMAN, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Sequence-specific DNA binding proteins are components of a nuclear matrix attachment site. Proc. Natl. Acad. Sci. USA 89: 4178-4182, 1992.
97. ECAROT-CHAHEIER, B., F. H. GLORIEUX, M. VAN DER REST, AND G. PEREIRA. Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J. Cell Biol. 96: 639-643, 1983.
98. EVANS, D. B., M. THAVARAJAH, AND J. A. KANIS. Involvement of prostaglandin E2 in the inhibition of osteocalcin synthesis by human osteoblast-like cells in response to cytokines and systemic hormones. Biochem. Biophys. Res. Commun. 167: 194-202, 1990.
99. FANTI, P., M. S. KINDY, S. MOHAPATRA, J. KLEIN, G. COLOMBO, AND H. H. MALLUCHE. Dose-dependent effects of aluminum on osteocalcin synthesis in osteoblast-like ROS 17/2 cells in culture. Am. J. Physiol 263 (Endocrinol. Metab. 26): E1113-E1118, 1992.
100. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129: 1876-1884, 1991.
101. FARACHE, G., S. V. RAZIN, J. RZESZOWSKA-WOLNY, J. MOREAU, F. R. TARGA, AND K. SCHERRER. Mapping of structural and transcription-related matrix attachment sites in the α-globin gene domain of avian erythroblasts and erythrocytes. Mol. Cell. Biol. 10: 5349-5358, 1990.
102. 3. J. Biol. Chem. 269: 2971-2981, 1994.
103. FEY, E. G., P. BANGS, C. SPARKS, AND P. ODGREN. The nuclear matrix: defining structural and functional roles. Crit. Rev. Eukaryotic Gene Expression 1: 127-143, 1991.
104. FEY, E. G., G. KROCHMALNIC, AND S. PENMAN. The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J. Cell Biol. 102: 1654-1665, 1986.
105. FEY, E. G., AND S. PENMAN. Nuclear-matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl. Acad. Sci. USA 85: 121-125, 1988.
106. FRANCESCHI, R. T., AND S. I. BHANUMATHI. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J. Bone Miner. Res. 7: 235-246, 1992.
107. 3 receptor in the absence of the retinoid X receptor. Mol. Endocrinol. 266: 265-273, 1994.
108. FRENKEL, B. F., J. MIJNES, M. A. ARONOW, G. ZAMBETTI, C. BANERJEE, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Position and orientation-selective silencer in protein-coding sequences of the rat osteocalcin gene. Biochemistry 32: 13636-13643, 1993.
109. FRENKEL, B. P., M. MONTECINO, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. A composite intragenic silencer domain exhibits negative and positive transcriptional control of the bone-specific osteocalcin gene: promoter and cell type requirements. Proc. Natl. Acad. Sci. USA 91: 10923-10927, 1994.
110. FRIEDENSTEIN, A. J., R. K. CHAILAKHJAN, AND K. S. LALYKINA. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3: 393-403, 1970.
111. FURUKAWA, K., Y. YAMAGUCHI, E. OGAWA, K. SHIGESADA, M. SATAKE, AND Y. ITO. A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors. Cell. Growth Differ. 1: 135-147, 1990.
112. GALLINARI, P., F. LABELLA, AND N. HEINTZ. Characterization and purification of H1TF2, a novel CCAAT-binding protein that interacts with a histone H1 subtype specific consensus element. Mol. Cell. Biol. 9: 1566-1575, 1989.
113. GASSER, S. M., AND U. K. LAEMMLI. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster. Cell 46: 521-530, 1986.
114. GEHRON-ROBEY, P., M. F. YOUNG, K. C. FLANDERS, N. S. ROCHE, A. H. KONDAIAH-REDDI, J. D. TERMINE, M. B. SPORN, AND A. B. ROBERTS. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J. Cell Biol. 105: 457-463, 1987.
115. GERBAULET, S. P., A. J. VAN WUNEN, N. ARONIN, M. S. TASSINARI, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Downregulation of histone H4 gene transcription during postnatal development in transgenic mice and at the onset of differentiation in transgenically derived calvarial osteoblast cultures. J. Cell. Biochern. 49: 137-147, 1992.
116. GERSTENFELD, L. C., M. BROESS, S. BRUDER, A. CAPLAN, AND W. J. LANDIS. Regulation of osteoblast extracellular matrix formation: post-translational regulation of extracellular matrix deposition and relationship between embryonic development and hormonal response. In: Chemistry and Biology of Mineralized Tissues, edited by H. Slavkin and P. Price. New York: Elsevier, 1992, p. 287-315.
117. GERSTENFELD, L. C., S. D. CHIPMAN, J. GLOWACKI, AND J. B. LIAN. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 122: 49-60, 1987.
118. GERSTENFELD, L. C., S. D. CHIPMAN, C. M. KELLY, K. J. HODGENS, D. D. LEE, AND W. J. LANDIS. Collagen expression, ultrastructural assembly, and mineralization in cultures of chicken embryo osteoblasts. J. Cell Biol. 106: 979-989, 1988.
119. GERSTENFELD, L. C., A. RIVA, K. HODGENS, D. R. EYRE, AND W. J. LANDIS. Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts. J. Bone Miner Res. 8: 1031-1039, 1993.
120. GETZENBERG, R. H., AND D. S. COFFEY. Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. Mol. Endocrinol. 4: 1336-1342, 1990.
121. GETZENBERG, R. H., AND D. S. COFFEY. Identification of nuclear matrix proteins in the cancerous and normal rat prostate. Canver Res. 51: 6514-6620, 1991.
122. GIERTHY, J. F., J. B. SILKWORTH, M. TASSINARI, G. S. STEIN, AND J. B. LIAN. 2,3,7,8-Tetrachlorodibenzo-P-dioxin inhibits differentiation of normal diploid rat osteoblasts in vitro. J. Cell. Biochem 54: 231-238, 1994.
123. 3- and butyrate-inducible responses. Proc. Natl. Acad Sci. USA 90: 2984-2988, 1993
124. GLASS, C. K., J. M. HOLLOWAY, O. V. DEVARY, AND M. G. ROSENFELD. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54: 313-323, 1988.
125. GLOBUS, R. K., P. PATTERSON-BUCKENDAHL, AND D. GOSPODAROWICZ. Regulation, of bovine bone cell proliferation by fibroblast growth factor and transforming growth factorβ. Endocrinology 123: 98-105, 1988.
126. GODSCHALK, M., J. R. LEVY, AND R. W. DOWNS. Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J. Bone Miner. Res. 130: 21-27, 1992.
127. GOLDRING, M. B., AND S. R. GOLDRING. Basic science and pathology skeletal tissue response to cytokines. Clin. Orthop. Relat. Res. 258: 245-278, 1990.
128. GRIGORIADIS, A. E., Z.-Q. WANG, AND E. F. WAGNER. c-fos oncogene expression in cartilage and bone tissues of transgenic and chimeric mice. In: Cellular and Molecular Biology of the Bone. New York: Academic, 1993, p. 497-537.
129. GRUSS, P., AND C. WALTHER. Pax in development Cell 69: 719-722, 1992.
130. GUIDON, P. T., R. SALVATORI, AND R. S. BOCKMAN. Gallium nitrate regulates rat osteoblast expression of osteocalcin protein and mRNA levels. J. Bone Miner. Res. 8: 103-110, 1993.
131. GUO, B., P. R. ODGREN, A. J. VAN WIJNEN, T. J. LAST, E. G. FEY, S. PENMAN, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. The nuclear matrix protein NMP-1 is the transcription factor YY-1. Proc. Natl. Acad. Sci. USA 92: 10526-10530, 1995.
132. GUO, B., A. J. VAN WIJNEN, P. ODGREN, T. J. LAST, J B LIAN, J. L. STEIN, AND G. S. STEIN. Cell cycle control of histone genes in proliferating osteoblasts: role of nuclear matrix associated transcription factor YY-1 in spatial gene regulatory mechanisms (Abstract). J. Bone Miner. Res. 10, Suppl.: S212, 1995.
133. 1NK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature Lond. 371: 257-261, 1994.
134. HARADA, H., T. FUJITA, M. MIYAMOTO, Y. KIMURA, M. MARUYAMA, A. FURIA, T. MIYATA, AND T. TANIGUCHI. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729-739, 1980.
135. HARADA, H., M. KITAGAWA, N. TANAKA, H. YAMAMOTO, K. HARADA, M. ISHIHARA, AND T. TANIGUCHI. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science Wash. DC 259: 971-974, 1993.
136. HARADA, H., E. TAKAHASHI, S. ITOH, K. HARADA, T. HORI, AND T. TANIGUCHI. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol. Cell. Biol. 14: 1500-1509, 1994.
137. 1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
138. HARRIS, M. E., R. BOHNI, M. H. SCHNEIDERMAN, L. RAMAMURTHY, D. SCHUMPERLI, AND W. F. MARZLUFF. Regulation of histone mRNA in the unperturbed cell cycle: evidence suggesting control at two posttranscriptional steps. Mol. Cell. Biol. 11: 2416-2424, 1991.
139. HARRIS, S. E., L. F. BONEWALD, M. A. HARRIS, M. SABATINI, S. DALLAS, J. FENG, N. GHOSH-CHOUDHURY, J. WOZNEY, AND G. R. MUNDY. Effects of TGFβ on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase and type 1 collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J. Bone Miner. Res. 9: 855-863, 1994.
140. HARRIS, S. E., M. SABATTNI, M. A. HARRIS, J. Q. FENG, J. WOZNEY, AND G. R. MUNDY. Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells. J. Bone Miner. Res. 9: 389-394, 1994.
141. HARVEY, R. P., A. J. ROBINS, AND J. R. E. WELLS. Independently evolving chicken histone H2B genes: identification of ubiquitous H2B-specific 5′ element. Nucleic Acids Res. 10: 7851-7863, 1982.
142. HATCH, C. L., AND W. M. BONNER. The human histone H2A. Z gene: sequence and regulation. J. Biol. Chem. 265: 15211-15218, 1990.
143. HAYNESWORTH, S. E., M. A. BABER, AND A. I. CAPLAN. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13: 69-80, 1992.
144. HAYNESWORTH, S. E., J. GOSHIMA, V. M. GOLDBERG, AND A. I. CAPLAN. Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88, 1992.
145. HE, D., J. A. NICKERSON, AND S. PENMAN. Core filaments of the nuclear matrix. J. Cell Biol. 110: 569-580, 1990.
146. HEERSCHE, J. N., S. M. REIMERS, J. L. WRANA, M. M. WAYE, AND A. K. GUPTA. Changes in expression of alpha 1 type 1 collagen and osteocalcin mRNA in osteoblasts and odontoblasts at different stages of maturity as shown by in situ hybridization. J. Proc. Finn. Dental Soc. 88, Suppl. 1: 173-182, 1992.
147. HEICHMAN, K. A., AND J. M. ROBERTS. Rules to replicate by. Cell 79: 557-562, 1994.
148. HEINRICHS, A. A. J., C. BANERJEE, R. BORTELL, T. A. OWEN, J. L. STEIN, G. S. STEIN, AND J. B. LIAN. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation. J. Cell. Biochem. 53: 240-250, 1993.
149. HEINRICHS, A. A. J., R. BORTELL, M. BOURKE, J. B. LIAN, G. S. STEIN, AND J. L. STEIN. Proximal promoter binding protein contributes to developmental, tissue-restricted expression of the rat osteocalcin gene. J. Cell. Biochem. 57: 90-100, 1995.
150. HEINRICHS, A. A. J., R. BORTELL, S. RAHMAN, J. L. STEIN, E. S. ALNEMRI, G. LITWACK, J. B. LIAN, AND G. S. STEIN. Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter. Biochemistry 32: 11436-11444, 1993.
151. HEINTZ, N. The regulation of histone gene expression during the cell cycle. Biochim. Biophys Acta 1088: 327-339, 1991.
152. HELMS, S. R., A. J. VAN WIJNEN, P. KROEGER, A SHIELS, C. STEWART, J. HIRSHMAN, J. L. STEIN, AND G. S. STEIN. Identification of an enhancer-like element upstream from a cell cycle dependent human H4 histone gene. J Cell. Physiol 132: 552-558, 1987.
153. HENDZEL, M. J., J.-M. SUN, H. Y. CHEN, J. B. RATTNER, AND J. R. DAVIE. Histone acetyltransferase is associated with the nuclear matrix. J. Biol. Chem. 269: 22894-22901, 1994.
154. HERMAN, R., L. WEYMOUTH, AND S. PENMAN. Heterogeneous nuclear RNA-protein fibers in chromatin-depleted nuclei. J. Cell Biol. 78: 663-674, 1978.
155. HINKLEY, C., AND M. PERRY. A variant octamer motif in a Xenopus H2B histone gene promoter is not required for transcription in frog oocytes. Mol. Cell. Biol. 11: 641-654, 1991.
156. 3 in bone cells. Biochim. Biophys. Acta 1174: 11-16, 1993.
157. HODGSON, S. F. Corticosteroid-induced osteoporosis. Endocrinol. Metab. Clin. N. Am. 19: 95-111, 1990.
158. HOFBAUER, R., AND D. T. DENHARDT. Cell cycle-regulated and proliferation stimulus-responsive genes. Crit. Rev. Eukaryotic Gene Expression 1: 247-300, 1991.
159. HOFFMANN, H. M., K. M. CATRON, A. J. VAN WIJNEN, L. R. McCABE, J. B. LIAN, G. S. STEIN, AND J. L. STEIN. Transcriptional control of the tissue-specific developmentally regulated osteocalcin gene requires a binding motif for the MSX-family of homeodomain proteins. Proc. Natl. Acad. Sci. USA 91: 12887-12891, 1994.
160. HOFFMANN, H. M., T. L. BEUMER, S. RAHMAN, L. R. McCABE, C. BANERJEE, F. ASLAM, J. A. TIRO, A. J. VAN WIJNEN, J. L. STEIN, G. S. STEIN, AND J. B. LIAN. Bone tissue-specific transcription of the osteocalcin gene: role of an activator osteoblast-specific complex and suppressor Hox proteins that bind the OC box. J. Cell. Biochem. In press.
161. HOLTHUIS, J., T. A. OWEN, A. J. VAN WIJNEN, K. L. WRIGHT, A. RAMSEY-EWING, M. B. KENNEDY, R. CARTER, S. C. COZENZA, K. J. SOPRANO, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science Wash. DC 247: 1454-1457, 1990.
162. HOROWITZ, M. C., A. FIELDS, J. ZAMPARO, D. HEYDEN, W. TANG, AND J. ELIAS. IL-11 secretion and its regulation in bone cells. J. Bone Miner. Res. 8, Suppl.: S143, 1993.
163. HOROWITZ, M. C., AND J. B. LEVY. The LIF/IL-6 subfamily of cytokines induce protein phosphorylation and signal transduction by nonreceptor tyrosine kinases in human and murine osteoblasts. Calcif. Tissue Int. 56, Suppl. 1: S32-S34, 1995.
164. HUNTER, T., AND J. PINES. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994.
165. IBARAKI, K., J. D. TERMINE, W. S. WHITSON, AND M. F. YOUNG. Bone matrix mRNA expression in differentiating fetal bovine osteoblasts. J. Bone Miner. Res. 7: 743-754, 1992.
166. IGNOTZ, R. A. TGF-β and extracellular matrix related influences on gene expression and phenotype. Eukaryotic Gene Expression 1: 75-84, 1991.
167. 3-induced inhibition of bone nodule formation in long term cultures of fetal rat calvarial cells. Endocrinology 132: 61-66, 1993.
168. IWASAKI, M., K. NAKATA, H. NAKAHARA, T. NAKASE, T. KIMURA, K. KIMATA, A. L. CAPLAN, AND K. ONO. Transforming growth factor-beta 1 stimulates chondrogenesis and inhibits osteogenesis in high density culture of periosteum-derived cells. Endocrinology 132: 1603-1608, 1993.
169. JACKSON, D. A. Structure-function relationships in eukaryoti nuclei. Bioessays 13: 1-10, 1991.
170. JACKSON, D. A., AND P. R. COOK. Transcription occurs at ; nucleoskeleton. EMBO J. 4: 919-925, 1985.
171. JACKSON, D. A., AND P. R. COOK. Replication occurs at ; nucleoskeleton. EMBO J. 5: 1403-1410, 1986.
172. JACKSON, D. A., S. J. McCREADY, AND P. R. COOK. RNA is synthe sized at the nuclear cage. Nature Lond. 292: 552-555, 1981.
173. JACKSON M. E., V. SHALHOUB, J. B. LIAN, G. S. STEIN, AND S. C MARKS, JR. Aberrant gene expression in cultured mammalian bon cells demonstrates an osteoblast defect in osteopetrosis. J Cel. Biochem 55: 366-372, 1994.
174. JARMAN, A. P., AND D. R. HIGGS. Nuclear scaffold attachmer sites in the human globin gene complexes. EMBO J. 7: 3337-334-1988
175. JAY, P., J. LORENZO, M. CENTRELLA, A. BRUCE, AND M. HORC WITZ. Oncostatin M: a new cytokine with osteoblast activating activity (Abstract). J. Bone Miner. Res 8, Suppl.: S302, 1993.
176. 3-indueed changes in intracellular pH in osteoblast-like cells modulate gene expression. J. Cell. Biochem. 53: 234-239, 1993.
177. JENIS, L. G., B. ONGPHIPHADHANAKUL, L. E. BRAVERMAN, G. S. STEIN, J. B. LIAN, R. LEW, AND D. T. BARAN. Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo. Calcif. Tissue Int. 54: 511-515, 1994.
178. JENIS, L. G., C. E. WAUD, G. S. STEIN, J. B. BARAN, AND D. T. LIAN. Effect of gallium nitrate in vitro and in normal rats. J. Cell. Biochem. 52: 330-336, 1993.
179. JOHNSON, R. S., B. M. SPIEGELMAN, AND V. PAPAIOANNOU. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71: 577-586, 1992.
180. JOHNSON, T. L., A. Y. SAKAGUCHI, P. A. LALLEY, AND R. J. LEACH. Chromosomal assignment in mouse of matrix Gla protein and bone Gla protein genes. Genomics 11: 770-772, 1991.
181. 3 and 22-oxacalcitriol in rat osteoblasts and by casein Wnase II, in vitro. Biochemistry 32: 8184-8192, 1993.
182. KARDALINOU, E., S. EICK, W. ALBIG, AND D. DOENECKE. Association of a human H1 histone gene with an H2A pseudogene and genes encoding H2B.1 and H3.1 histones. J. Cell. Biochem. 52: 375-383, 1993.
183. KAS, E., AND L. A. CHASIN. Anchorage of the Chinese hamster dihydrofolate reductase gene to the nuclear scaffold occurs in an intragenic region. J. Mol. Biol. 198: 677-692, 1987.
184. KATAGIRI, T., A YAMAGUCHI, T. IKEDA, S. YOSHIKI, J. M. WOZNEY, V. ROSEN, E. A. WANG, H. TANAKA, S. OMURA, AND T. SUDA. The non-osteogenic mouse pluripotent cell line, C3H10T1/ 2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172: 295-299, 1990.
185. 3 in rat osteoblastic osteosarcoma cells. Proc. Natl. Acad. Sci. USA 89: 4569-4572, 1992.
186. KEETING, P. E., R. E. SCOTT, D. S. COLVARD, M. A. ANDERSON, M. J. OURSLER, T. C. SPELSBERG, AND B. L. RIGGS. Development of a rapidly proliferating, well-differentiated cell line derived from normal adult human osteoblast-like cells bransfected with SV40 large T antigen. J. Bone Miner. Res. 7: 127-136, 1992.
187. KEPPEL, F. Transcribed human ribosomal RNA genes are attached to the nuclear matrix. J. Mol. Biol. 187: 15-21, 1986.
188. 3. Proc. Natl. Acad. Sci. USA 86: 4455-4459, 1980.
189. KERR, L. D., D. B. MILLER, AND L. M. MATRISLAN. TGF-β inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 61: 267-278, 1990.
190. KESTERSON, R. A., L STANLEY, F. DEMAYO, M. FTNEGOLD, AND J. W. PIKE. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice. Mol. Endocrinol. 7: 462-467, 1993.
191. KING, K. L., AND J. A. CIDLOWSKI. The cell cycle and apoptosis: common pathways to life and death. J. Cell. Biochem. 58: 175-180, 1995.
192. KINGSLEY, D. M. The TGFβ superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133-146, 1994.
193. KLIEWER, S. A., K. UMESONO, D. J. MANGELSDORF, AND R. M. EVANS. Retinoic X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone an vitamin D signalling. Nature Land. 355: 441-446, 1992.
194. KNIGHT, G. B., J. M. GUDAS, AND A. B. PARDEE Coordinate control of S phase onset and thymidine kinase expression. J. Cancer Res. 80: 493-498, 1989.
195. KOCKX, M., L. McCABE, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Influence of DNA replication inhibition on expression of cell growth and tissue specific genes in osteoblasts and osteosarcoma cells. J. Cell. Biochem. 54: 47-55, 1994.
196. KOFF, A., F. CROSS, A. FISHER, J SCHUMACHER, K. LEGUELLEC, M. PHILIPPE, AND J. M. ROBERTS. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66: 1217-1228, 1991.
197. KOMM, B. S., S. WANG, J. G. HADDAD, JR., AND C. R. LYTTLE. Characterization of conditionally transformed osteoblast-like cells derived from rat calvaria. J. Bone Miner. Res. 8, Suppl.: S359, 1993.
198. KHOEGER, P., C. STEWART, T. SCHAAP, A. VAN WIJNEN, J. HIRSHMAN, S. HELMS, G. STEIN, AND J. STEIN. Proximal and distal regulatory elements that influence in vivo expression of a cell cycle dependent H4 histone gene. Proc. Natl. Acad. Sci. USA 84: 3982-3986, 1987.
199. KROEGER, P. E., A. J. VAN WIJNEN, U. PAULI, K. L. WEIGHT, G. S. STEIN, AND J. L. STEIN. In vivo occupancy of histone gene proximal promoter elements reflects gene copy number-dependent titratable transactivation factors and cross-species compatibility of regulatory sequences. J. Cell. Biochem. 57: 191-207, 1995.
200. KRUMLAUF, R. Hox genes and pattern formation in the branchial region of the vertebrate head. Trends Genet. 9: 106-112, 1993.
201. KUMARA-SIRI, M. H., L. E. SHAPIRO, AND M. I. SURKS. Association of the 3,5,3′-triiodo-L-thyronine nuclear receptor with the nuclear matrix of cultured growth hormone-producing rate pituitary tumor cells (GC cells). J. Biol. Chem. 261: 2844-2852, 1980.
202. 3 stimulated osteocalcin gene transcription by tumor necrosis factor-α: structural determinants within the vitamin D response element. Endocrinology 134: 2524-2531, 1994.
203. LABELLA, F., H. L. SIVE, R. G. ROEDER, AND N. HEINTZ. Cell cycle regulation of a human histone H2b gene is mediated by the H2B subtype-specific DNA consensus element. Genes Dev. 2: 32-39, 1989.
204. LAJEUNESSE, D., G. M. KIEBZAK, C. FRONDOZA, AND B. SACKTOR. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner. 14: 237-250, 1991.
205. LANDERS, J. P., AND T. C. SPELSBERG. New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit. Rev. Eukaryotic Gene Expression 2: 19-63, 1992.
206. LAWRENCE, J. B., L. M. MARSELLE, K. S. BYRON, C. V. JOHNSON, J. L. SULLIVAN, AND R. H. SINGER. Subcellular localization of low-abundance human immunodeficiency virus nucleic acid sequences visualized by fluorescence in situ hybridization. Proc. Natl. Acad Sci. USA 87: 5420-5424, 1990.
207. LEBOY, P. S., J. N. BERESFORD, C. DEVLIN, AND M. E. OWEN. Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J. Cell. Physiol. 146: 370-378, 1991.
208. LEE, I. J., L. TUNG, D. A. BUMCROT, AND E. S. WEINBERG. UHF-1, a factor required for maximal transcription of early and late sea urchin histone H4 genes: analysis of promoter-binding sites Mol. Cell. Biol 11: 1048-1061, 1991.
209. LEE, K., J. D. DEEDS, S. CHIBA, M. UN-NO, A. T. BOND, AND G V. SEGRE. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 134: 441-450, 1994.
210. LEVINE, B. J., N. CHODCHOY, W. F. MARZLUFF, AND A. SKOULTCHI. Coupling of replication type histone mRNA levels to DNA synthesis requires the stem-loop sequence at the 3′ end of the mRNA. Proc. Natl. Acad. Sci. USA 84: 6189-6193, 1987.
211. LEVINE, M., AND J. L. MANLEY. Transcriptional repression of eukaryotic promoters. Cell 59: 405-408, 1989.
212. LEVY, J. B., R. BARON, AND M. C. HOROWITZ. Oncostatin-M induces signal transduction by non-receptor tyrosine kinases in primary osteoblasts. J. Bone Miner: Res. 9, Suppl.: S149, 1994.
213. LEVY, R. J., J. B. LIAN, AND P. M. GALLOP. Atherocalcin, a y-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem. Biophys. Res. Commun. 91: 412D49, 1979.
214. 1-S phase transcriptional regulation. Proc. Natl. Acad. Sci. USA 90: 3554-3558, 1993.
215. LI, Y.-P., W. CHEN, AND P. STASHENKO. Characterization of a silencer element in the first exon of the human osteocalcin gene. Nucleic Acids Res. 23: 5064-5072.
216. LI, Y., AND P. STASHENKO. Characterization of a tumor necrosis factor-responsive element which down-regulates the human osteocalcin gene. Mol. Cell. Biol. 13: 3714-3721, 1993.
217. LIAN, J. B., M. D. McKEE, A. M. TODD, AND L. C. GERSTENFELD. Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J. Cell. Biochem. 52: 206-219, 1993.
218. LIAN, J. B., AND G. S. STEIN. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit. Rev. Oral Biol. Med. 3: 269-305, 1992.
219. LIAN, J. B., AND G. S. STEIN. Transcriptional control of vitamin D-regulated proteins. J. Cell. Biochem. 49: 37-45, 1992.
220. LIAN, J. B., AND G. S. STEIN. Vitamin D regulation of osteoblast growth and differentiation. In: Nutrition and Gene Expression, edited by C. D. Berdanier and J. L. Hargrove: Boca Raton, FL: CRC, 1992, p. 391-429.
221. LIAN, J. B., AND G. S. STEIN. Proto-oncogene mediated control of gene expression during osteoblast differentiation. Ital. J. Miner. Elect. Metab. 7: 175-183, 1993.
222. LIAN, J. B., G. S. STEIN, R. BORTELL, AND T. A. OWEN. Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by fos/jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-speciflc genes. J. Cell. Biochem. 45: 9-14, 1991.
223. LIAN, J. B., G. S. STEIN, T. A. OWEN, R. BORTELL, V. SHALHOUB, A. HEINRICHS, W. C. VAN ORDT, AND A. J. VAN WIJNEN. Hormonal influence on expression of growth (H4 histone) and differentiation (osteocalcin) genes is dependent on developmental stage of the osteoblast: modification of these regulatory controls in tumor cells. In: Chemistry and Biology of Mineralized Tissues, edited by H. Slavkin and P. Price. Amsterdam: Excerpta Medica, 1992, p. 307-316.
224. LIAN, J. B., G. S. STEIN, T. A. OWEN, M. S. TASSINARI, M. ARONOW, D. COLLART, V. SHALHOUB, S. PEURA, S. DWORETZKY, J. BIDWELL, AND S. POCKWINSE. Gene expression during development of the osteoblast phenotype: an integrated relationship of cell growth to differentiation. In: Molecular and Cellular Approaches to the Control of Proliferation and Differentiation. San Diego, CA: Academic, 1992, p. 165-222.
225. LIAN, J. B., G. S. STEIN, J. L. STEIN, R. BORTELL, T. A. OWEN, V. SHALHOUB, A. HEINRICHS, C. W. VAN OORDT, AND A. J. VAN WIJNEN. Implications of abrogated growth control on expression of a cell cycle-regulated histone and the osteoblast-speciflc osteocalcin genes in osteosarcoma cells. In: Frontiers of Osteosarcoma Research, edited by J. F. Novak and J. H. McMaster. Kirkland, WA; Hogrefe & Huber, 1993, p. 227-287.
226. LIAN, J. B., C. STEWART, E. PUCHACZ, S. MACKOWIAK, V. SHALHOUB, D COLLART, G. ZAMVETTI, AND G. S. STEIN. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc. Natl. Acad. Sci. USA 86: 1143-1147, 1989.
227. LICHTLER, A. C., F. SIERRA, S. CLARK, J. R. E. WELLS, J. L. STEIN, AND G. S. STEIN. Multiple H4 histone mRNAs of HeLa cells are encoded in different genes. Nature Lond. 298: 195-198, 1982.
228. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J. Biol. Chem. 262: 13168-13173, 1987.
229. LIU, F., L. MALAVAL, A. K. GUPTA, AND J. E. AUBIN. Simultaneous detection of multiple bone-related mRNAs and protein expression during osteoblast differentiation: polymerase chain reaction and immunocytochemical studies at the single cell level. Dev. Biol. 166: 220-234, 1994.
230. LOESER, R. F., JR., AND R. WALLIN. Vitamin K-dependent carboxylation in articular chondrocytes. Connect. Tissue Res. 26: 135-144. 1991.
231. LOESER, R. F., JR., AND R. WALLIN. Cell adhesion to matrix Gla protein and its inhibition by an Arg-Gly-Asp-containing peptide. J. Biol. Chem. 267: 9459-9462, 1992.
232. LONG, M. S., J. L. WILLIAMS, AND K. G. MANN. Expression of human bone-related proteins in the hematopoietic microenvironment. J. Clin. Invest. 86: 1387-1395, 1990.
233. LOWE, K. E., A. C. MAIYAR, AND A. W. NORMAN. Vitamin D-mediated gene expression. Eukaryotic Gene Expression 2: 65-109, 1992.
234. LUFKIN, T., A. DIERICH, M. LEMEUR, M. MARK, AND P. CHAMBON. Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 66: 1105-1119, 1991.
235. LUFKIN, T., M. MARK, C. P. HART, M. LEMEUR, AND P. CHAMBON. Homeotic transformation of the occipital bones of the skull by ectopic expression of a homeobox gene. Nature Lond. 359: 835-841, 1992.
236. LUKERT, B. P., AND L. G. RAISZ. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. Intern. Med. 112: 352-364, 1990.
237. LYNCH, M. P., J. L. STEIN, G. S. STEIN, AND J. B. LIAN. Apoptosis during in vitro bone formation (Abstract). J. Bone Miner. Res. 9, Suppl.: S352, 1994.
238. LYNCH, M. P., J. L. STEIN, G. S. STEIN, AND J. B. LIAN. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp. Cell Res. 216: 35-45, 1995.
239. LYONS, K. M., R. W. HOGAN, AND B. L. M. PELTON. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-β-like genes coordinately regulate aspects of embryonic development. Genes Dev. 1: 1657-1668, 1989.
240. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13: 5907-5917, 1993.
241. MACLACHLAN, T. K., N. SANG, AND A. GIORDANO. Cyclins, cyclin-dependent kinases and Cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryotic Gene Expression 5: 127-156, 1995.
242. MAJESKA, R. J., B. C. NAIR, AND G. A. RODAN. Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8. Endocrinology 116: 170-179, 1985.
243. MAJESKA, R. J., S. B RODAN, AND G. A. RODAN. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines. Exp. Cell Res. 111: 465-472, 1978.
244. MAJESKA, R. J., S. B. RODAN, AND G. A. RODAN. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107. 1494-1499, 1980.
245. MANDAL, N., W. SU, R. HABER, S. ADHYA, AND H. ECHOLS. DNA looping in cellular repression of transcription of the galactose operon. Genes Dev. 4: 410-418, 1990.
246. MARCELLI, C., A. J. YATES, AND G. R. MUNDY. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice. J. Bone Miner. Res 5: 1087-1096, 1990.
247. MARIE, P. J. Human osteoblastic cells: a potential tool to assess the etiology of pathologic bone formation. J. Bone Miner. Res. 9: 1847-1850, 1994.
248. MARIE, P. J., M. C. DE VERNEJOUL, D. CONNES, AND M. HOTT. Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation. J. Clin. Invest. 88: 1167-1172, 1991.
249. MARIMAN, E. C. M., C. A. G. VAN EEKELEN, J. REINDERS, A. J. M. BERNS, AND W. J. VAN VENROOIJ. Adenoviral heterogenous nuclear RNA is associated with the host nuclear matrix during splicing. J. Mol. Biol. 154: 103-119, 1982.
250. MARK, M. P., C. W. PRINCE, S. GAY, R. L. AUSTIN, M. BHOWN, R. D. FINKELMAN, AND W. T. BUTLER A comparative immunocytochemical study on the subcellular distributions of 44 kDa bone phosphoprotein and bone gammacarboxyglutamic acid (Gla)-containing protein in osteoblasts. J. Bone Miner. Res. 2: 337-346, 1987
251. 1-S phase transcriptional regulation. Proc. 2 Natl. Acad. Sci. USA 90: 3554-3558, 1993.
252. MARUSIC, A., J. F. KALINOWSKI, S. JASTRZEBSKI, AND J. A. LORENZO. Production of leukemia inhibitory factor mRNA and protein by malignant and immortalized bone cells. J. Bone Miner. Res. 8: 617-624, 1993.
253. MARZLUFF, W. F., AND N. B. PANDEY. Multiple regulatory steps control histone mRNA concentrations. Trends Biochem. Sci. 13: 49-52, 1988.
254. MASI, L., A. FRANCHI, M. SANTUCCI, D. DANIELLI, L. ATGANINI, V. GIANNONE, L. FORMIGLI, S. BENVENUTI, A. TANINI, F. BEGHE, M. MIAN, AND M. L. BRANDI. Adhesion, growth and matrix production by osteoblasts on collagen substrata. Calcif. Tissue Int. 51: 202-212, 1992.
255. 3 receptors in osteoblastic ROS 17/2.8 cells. J. Bone Miner. Res. 8: 997-1003, 1993.
256. McCABE, L., C. BANERJEE, J. STEIN, J. LIAN, AND G. STEIN. Developmental expression of fos and jun family members is functionally related to the stage of osteoblast growth and differentiation and bone formation (Abstract). J. Bone Miner. Res. 10, Suppl. 1: S213, 1995
257. McCABE, L. R., M. KOCKX, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Selective expression of fos and jun related genes during osteoblast proliferation and differentiation. Exp. Cell Res. 218: 255-262, 1995.
258. McGINNIS, W., AND R. KRUMLAUF. Homeobox genes and axial patterning. Cell 68: 283-302, 1992.
259. McKEE, M. D., AND A. NANCI. Ultrastructural, cytochemical and immunocytochemical studies of bone and its interfaces. Cell Mater. 3: 219-243, 1993
260. MERRIMAN, H., A. J. VAN WIJNEN, J. P. BIDWELL, E. FEY, S. HIEBERT, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. A tissue-restricted AML-1-related nuclear matrix protein, NMP-2, binds the osteocalcin gene promoter. Biochemistry 34: 13125-13132, 1995.
261. MIRKOVITCH, J., S. M. GASSER, AND U. K. LAEMMLI. Scaffold attachment of DNA loops in metaphase chromosomes. J. Mol. Biol. 200: 101-109, 1988.
262. MIRKOVITCH, J., M.-E. MIRAULT, AND U. K. LAEMMLI. Organization of the higher-order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39: 223-232, 1984.
263. MOHAN, S., AND D. BAYLINK. Bone growth factors. Clin. Orthop. Relat. Res. 263: 30-48, 1990.
264. MONTECINO, M., J. LIAN, G. STEIN, AND J. STEIN. Specific nucleosomal organization supports developmentally regulated expression of the osteocalcin gene. J. Bone Miner. Res. 9, Suppl.: S352, 1994.
265. MONTECINO, M., S. POCKWINSE, J. LIAN, G. STEM, AND J. STEIN. DNase I hypersensitive sites in promoter elements associated with basal and vitamin D dependent transcription of the bone-speciflc osteocalcin gene. Biochemistry 33: 348-353, 1994.
266. MORENO, M. L., S. A. CHRYSOGELOS, G. S. STEIN, AND J. L. STEIN. Reversible changes in the nucleosomal organization of a human H4 histone gene during the cell cycle. Biochemistry 25: 5364-5370, 1986.
267. MORENO, M. L., G. S. STEIN, AND J. L. STEIN. Nucleosomal organization of a BPV minichromosome containing a human H4 histone gene. Mol. Cell. Biochem. 74: 173-177, 1987.
268. MORRIS, T. D., L. A. WEBER, E. HICKEY, G. S. STEIN, AND J. L. STEIN. Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle. Mol Cell. Biol. 11: 544-553, 1991.
269. MORRISON, N., AND J. EISMAN. Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter. J. Bone Miner. Res. 8: 969-975, 1993.
270. MORRISON, N., J. C. QI, A. TOKITA, P. J. KELLY, L. CROFTS, T. V. NGUYEN, P. N. SAMBROOK, AND J. A. EISMAN. Prediction of bone density from vitamin D receptor alleles. Nature Lond. 367: 284-287, 1994.
271. MORRISON, N., J. SHINE, J. C. FRAGONAS, V. VERKEST, L. McMENEMY, AND J. A. EISMAN. 1,25-Dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science Wash. DC 246: 1158-1161, 1989.
272. MORRISON, N., R. YEOMAN, P. KELLY, AND J. EISNLAN. Contribution of transacting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc. Natl. Acad Sci. USA 89: 6665-6669, 1992.
273. MURRAY, S., C. GLACKLN, K. A. WINTERS, D. GAZIT, A. J. KAHN, AND E. J. MURRAY. Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. Bone Miner. Res. 7: 1131-1138, 1992.
274. NAKAGAWA, Y., C. L. RENZ, M. AHMED, AND F. L. COE. Isolation of nephrocalcin from kidney tissue of nine vertebrate species. Am. J. Physiol. 263 (Renal Fluid Electrolyte PhysioL 32): F243-F248, 1991.
275. NAKAHARA, H., S. P. BRUDER, S. E. HAYNESWORTH, J. J. HOLECEK, M. A. BABER, V. M. GOLDBERG, AND A. I. CAPLAN. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 11: 181-188, 1990.
276. NAKAYASU, H., AND R. BEREZNEY. Mapping replicational sites in the eukaryotic nucleus. J. Cell Biol. 108: 1-11, 1989.
277. 3 and tumor necrosis factor-á in the rat osteocalcin gene. Endocrinology 134: 1113-1120, 1994.
278. 3-stimulated synthesis of bone Gla protein in rat osteosarcoma cells by a pretranslational mechanism. Endocrinology 127: 588-594, 1990.
279. 3-stimulated bone gla protein synthesis in rat osteosarcoma cells (ROS 17/2.8) by a pretranslational mechanism. Endocrinology 128: 2577-2582, 1991.
280. NEFUSSI, J.-R., M. L. BOY-LEFEVRE, H. BOULEKBACHE, AND N. FOREST. Mineralization in vitro of matrix formed by osteoblasts isolated by collagenase digestion. Differentiation 29: 160-168, 1985.
281. NELKIN, B. D., D. M. PARDOLL, AND B. VOGELSTEIN. Localization of SV40 genes with supercoiled loop domains. Nucleic Acids Res 8: 5623-5633, 1980.
282. NELSON, W. G., K. J. PIENTA, E. R. BARRACK, AND D. S. COFFEY. The role of the nuclear matrix in the organization and function of DNA. Nucleic Acids Res. 14: 6433-6451, 1986.
283. NICKERSON, J. A., D. HE, E. G. FEY, AND D. S. COFFEY. The nuclear matrix. In: The Eukaryotic Nucleus. Molecular Biochemistry and Macromolecular Assemblies, edited by P. R. Strauss and S. H. Wilson. Caldwell, NJ: Telford, 1990, p. 763.
284. NICKERSON, J. A., G. KROCKMALNIC, D. HE, AND S. PENMAN. Immunolocalization in three dimensions: immunogold staining of cytoskeletal and nuclear matrix proteins in resinless electron microscopy sections. Proc. Natl. Acad. Sci. USA 87:2259-2263, 1960.
285. NICKERSON, J. A., AND S. PENMAN. The nuclear matrix: structure and involvement in gene expression. In: Molecular and Cellular Approaches to the Control of Proliferation and Differentiation. San Diego, CA: Academic, 1992, p. 434-380.
286. NIEHRS, C., AND E. M. DEROBERTIS. Vertebrate axis formation. Curr. Opin. Genet. Dev. 2: 550-555, 1992.
287. NIGG, E. A. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol. 5: 187-193, 1993.
288. NIJWEIDE, P. J., AND R. J. P. MULDER. Identification of osteocytes in osteoblast-like cell cultures using a monoclonal antibody specifically directed against osteocytes. Histochemistry 84: 342-347, 1986.
289. 3 on bone γ-carboxyglutamic acid protein synthesis by rat osteosarcoma cells. J. Bone Miner. Res. 2: 571-577, 1987.
290. NODA, M. Transcriptional regulation of osteocalcin production by transforming growth factor-β in rat osteoblast-like cells. Endocrinology 124: 612-617, 1989.
291. NODA, M., AND J. J. CAMILLIERE. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124: 2991-2994, 1989.
292. 3 enhancement of mouse secreted phosphoprotein 1 (Sp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 87: 9995-9999, 1990.
293. NOMURA, S., A. J. WILLS, D. EDWARDS, J. K. HEATH, AND B. L. M. HOGAN. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106: 441-450, 1988.
294. 3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 50: 6857-6864, 1990.
295. NURSE, P. Ordering S phase and M phase in the cell cycle. Cell 79: 547-550, 1994.
296. 1. Biochem. Biophys. Res. Commun. 180: 1194-1199, 1991.
297. 3 gene. J. Biol. Chem. 269: 10545-10550, 1994.
298. OSLEY, M. A. The regulation of histone synthesis in the cell cycle. Annu. Rev Biochem. 60: 827-861, 1991.
299. OURSLER, M. J. Osteoclast synthesis and secretion and activation of latent transforming growth factor β. J. Bone Miner. Res. 9: 443-452, 1994.
300. OWEN, M. The origin of bone cells in the postnatal organism. Arthritis Rheum. 23: 1073-1078, 1980.
301. OWEN, M. Marrow stromal stem cells. J. Cell Sci. Suppl. 10: 63-76, 1988.
302. OWEN, T. A., M. A. ARONOW, L. M. BARONE, B. BETTENCOURT, G. STEIN, AND J. B. LIAN. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 1496-1504, 1991.
303. OWEN, T. A., M. ARONOW, V. SHALHOUB, L. M. BARONE, L. WILMING, M. S. TASSINARI, M. B. KENNEDY, S. POCKWINSE, J. B. LIAN, AND G. S. STEIN. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143: 420-430, 1990.
304. OWEN, T. A., R. BORTELL, V. SHALHOUB, A. HEINRICHS, J. L. STEIN, G. S. STEIN, AND J. B. LIAN. Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc. Natl. Acad. Sci. USA 90: 1503-1507, 1993.
305. OWEN, T. A., R. BORTELL, S. A. YOCUM, S. L. SMOCK, M. ZHANG, C. ABATE, V. SHALHOUB, N. ARONIN, K. L. WRIGHT, A. J. VAN WIJNEN, J. L. STEIN, T. CURRAN, J. B. LIAN, AND G. S. STEIN. Coordinate occupancy of AP-1 sites in the vitamin D responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Proc. Natl. Acad. Sci. USA 87: 9990-9994, 1990.
306. OWEN, M., AND and A. J. FRIEDENSTEIN. Stromal stem cells: marrow-derived osteogenic precursors. In: Cell and Molecular Biology and Vertebrate Hard Tissues, edited by D. Evered and S. Harneet. Chichester, UK: Wiley, 1988, p. 42-60.
307. OWEN, T. A., J HOLTHUIS, E. MARKOSE, A. J. VAN WIJNEN, S. A. WOLFE, S. GRIMES, J. B. LIAN, AND G. S. STEIN. Modifications of protein-DNA interactions in the proximal promoter of a cell-growth-regulated histone gene during onset and progression of osteoblast differentiation. Proc. Natl. Acad Sci. USA 87: 5129-5133, 1990.
308. 3. J. Bone Miner. Res. 6: 1021-1027, 1991.
309. 3 receptor in rat osteosarcoma cells. J. Biol. Chem. 262: 4670-4675, 1987.
310. PANDEY, N. B., AND W. F. MARZLUFF. The stem-loop structure at the 3' end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability. Mol. Cell. Biol. 7: 4557-4559, 1987.
311. 1 events and regulation of cell proliferation. Science Wash. DC 246: 603-608, 1989.
312. PARDOLL, D. M., B. VOGELSTEIN, AND D. S. COFFEY. A fixed site of DNA replication in eukaryotic cells. Cell 19: 527-536, 1980.
313. 3 induced osteoclast development. J. Bone Miner. Res. 7, Suppl.: S110, 1992.
314. PAULI, U., J. F. CHIU, P. DITULLIO, P. KROEGER, V. SHALHOUB, T. ROWE, G. S. STEIN, AND J. L. STEIN. Specific interactions of histone Hl and a 45 kilodalton nuclear protein with a putative matrix attachment site in the distal promoter region of a cell cycle-regulated human histone gene. J. Cell. Physiol. 139: 320-328, 1989.
315. PAULI, U., S. CHRYSOGELOS, J. STEIN, G. STEIN, AND H. NICK, Protein-DNA interactions in vivo upstream of a cell cycle regulated human H4 histone gene. Science Wash. DC 236: 1308-1311, 1987.
316. PECK, W. A., S. J. BIRGE, AND S. A. FEDAK. Bone cells: biochemical and biological studies after enzymatic isolation. Science Wash. DC 146: 1476-1477, 1964.
317. PELTZ, S. W., G. BREWER, P. BERNSTEIN, P. A. HART, AND J. ROSS. Regulation of mRNA turnover in eukaryotic cells. Crit Rev. Eukaryotic Gene Expression 1: 99-126, 1991.
318. PFEILSCHIFTER, J., I. DIEL, U. PILZ, K. BRUNOTTE, A. NAUMANN, AND R ZIEGLER. Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age. J. Bone Miner. Res. 8: 707-717, 1993.
319. PHI-VAN, L., AND W. H. STRATLING. The matrix attachment regions of the chicken lysozyme gene co-map with the boundaries of the chromatin domain. EMBO J. 7: 655-664, 1988.
320. PHI-VAN, L., J. P. VON KRIES, W. OSTERTAG, AND W. H. STRÄTLING. The chicken lysozyme 5′ matrix attachment region increases transcription from a heterologous promoter in heterologous cells and dampens positional effects on the expression of transfected genes. Mol. Cell. Biol. 10: 2302-2307, 1990
321. PIENTA, K. J., AND D. S COFFEY. Correlation of nuclear morphometry with progression of breast cancer. Cancer 68: 2012-2016, 1991.
322. PIENTA, K. J., R. H. GETZENBERG, AND D. S. COFFEY. Cell structure and DNA organization. Crit. Rev Eukaryotic Gene Expression 1: 355-385, 1991.
323. PIERCE, J. W., A. M. GIFFORD, AND D. BALTIMORE. Silencing of the expression of the immunoglobulin kappa gene in non-B cells. Mol. Cell Biol. 11: 1431-1437, 1991.
324. PLUMB, M. A., J. L. STEIN, AND G. S. STEIN. Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res. 11: 2391-2410, 1983.
325. PLUMB, M. A., J. L. STEIN, AND G. S. STEIN. Influence of DNA synthesis inhibition on the coordinate expression of core human histone genes. Nucleic Acids Res. 11: 7927-7945, 1983.
326. POCKWINSE, S. M., J. B. LAWRENCE, R. H. SINGER, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Gene expression at single cell resolution associated with development of the bone cell phenotype: ultrastructural and in situ hybridization analysis. Bone 14: 347-352, 1993.
327. POCKWINSE, S. M., J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Developmental stage-specific cellular responses to vitamin D and glucocorticoids during differentiation of the osteoblast phenotype: interrelationships of morphology and gene expression by in situ hybridization. Exp. Cell Res. 216: 244-260, 1995.
328. POCKWINSE, S. M., L. WILMING, D. CONLON, G. S. STEIN, AND J. B. LIAN Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osleoblast cultures. J. Cell. Biochem. 49: 310-323, 1992.
329. PUCHACZ, E., J. B. LIAN, G. S. STEIN, J. WOZNEY, K. HUEBNER, AND C. CROCE. Chromosomal localization of the human osteocalcin gene. Endocrinology 124: 2648-2650, 1989.
330. QUARLES, L. D., D. A. YOHAY, L. W. LEVER, R. CATON, AND R. J. WENSTRUP. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J. Bone Miner. Res. 7: 683-692, 1992.
331. RAHMAN, S., A. OBERDORF, M. MONTECINO, S. M. TANHAUSER, J. B. LIAN, G. S. STEIN, P. J. LAIPIS, AND J. L. STEIN. Multiple copies of the bone-specific osteocalcin gene in mouse and rat. Endocrinology 133: 3050-3053, 1993.
332. RAISZ, L. G. Bone cell biology: new approaches and unanswered questions. J. Bone Miner. Res. 8, Suppl: S457-S462, 1993.
333. RAMSEY-EWING, A., A, VAN WIJNEN, G. S. STEIN, AND J. L. STEIN. Delineation of a human histone H4 cell cycle element in vivo: the master switch for H4 gene transcription. Proc. Natl. Acad. Sci. USA 91: 4475-4479, 1994.
334. REID, I. R., G. E. CHAPMAN, T. R. C. FRASER, A. D. DAVIES, A. S. SURUS, J. MEYER, N. L. HYQ, AND H. K. IBBERTSON. Low serum osteocalcin levels in glucocorticoid-treated asthmatics. J. Clin. Endocrinol. Metab. 62: 379-385, 1986.
335. REID, I., C. LOWE, J. CORNISH, S. SKINNER, D. HILTON, R. WILLSON, D. GEARING, AND T. MARTIN. Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology 126: 1416-1420, 1990.
336. RICCIO, A., P. V. PEDONE, L. F. LUND, T. OLESEN, T. OLSEN, H. S. OLSEN, AND P. A. ANDREASEN. Transforming growth factor β1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type I plasminogen activator inhibitor gene. Mol. Cell. Biol. 12: 1846-1855, 1992.
337. RICKLES, R., F. MARASHI, F. SIERRA, S. CLARK, J. WELLS, J. STEIN, AND G. STEIN. Analysis of histone gene expression during the cell cycle in HeLa cells by using cloned human histone genes. Proc. Natl. Acad. Sci. USA 79: 749-753, 1982.
338. ROBERTS, S. B., N. SEGIL, AND N. HEINTZ. Oct1 (OTF1) is differentially phosphorylated during the cell cycle. Science Wash. DC 253: 1022-1026, 1991.
339. ROBEY, P. G., AND J. D. TERMINE. Human bone cells in vitro. Calcif. Tissue Int. 37: 453-460, 1985.
340. ROBINSON, S. I., B. D. NELKIN, AND B. VOGELSTEIN. The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells. Cell 28: 99-106, 1982.
341. RODAN, G. A., AND M. NODA Gene expression in osteoblastic cells. Crit. Rev. Eukaryotic Gene Expression 1: 85-98, 1980.
342. ROODMAN, G. D. Interleukin-6: an osteotropic factor? J. Bone Miner. Res. 7: 475-478, 1992.
343. ROSS, D. A., R. W. YEN, AND C. B. CHAE. Association of globin ribonucleic acid and its precursors with the chicken erythroblast nuclear matrix. Biochemistry 21: 764-771, 1982.
344. ROSS, T. K., H. M. DARWISH, V. E. MOSS, AND H. F. DELUCA. Vitamin D-influenced gene expression via a ligand-independent, receptor-DNA complex intermediate. Proc. Natl. Acad. Sci. USA 90: 9257-9260, 1993.
345. ROSS, T. K., V. E. MOSS, J. M. PRAHL, AND H. F. DELUCA. A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements. Proc. Natl. Acad. Sci. USA 89: 256-260, 1992.
346. ROSSI, P., G. KARSENTY, A. B. ROBERTS, N. S. ROCHE, M. B. SPORN, AND B. CROMBUGGHE. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 52: 405-414, 1988.
347. ROY, R. J., P. GOSSELIN, M. J. ANZIVINO, D. D. MOORE, AND S. L. GUERIN. Binding of a nuclear protein to the rat growth hormone silencer element. Nucleic Acids Res. 20: 401-408, 1992.
348. RUTHER, U., C. GARBER, D. KOMITOWSKI, R. MULLER, AND E. F. WAGNER. Deregulation of c-fos expression interferes with normal bone development in transgenic mice. Nature Lond. 325: 412-416, 1987.
349. SAMPATH, T. K., J. C. MALIAKAL, P. V. HAUSCHKA, W. K. JONES, H. SASAK, R. F. TUCKER. K. H. WHITE, J. E. COUGHLIN, M. M. TUCKER, AND R. H. PANG. Recombinant human ostcogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267: 20352-20362, 1992.
350. SAVAGNER, P., T. MIYASHITA, AND Y. YAMADA. Two silencers regulate the tissue-specific expression of the collagen II gene. J. Biol. Chem. 265: 6669-6674, 1990.
351. SCHAACK, J., W. Y.-W. HO, P. FREIMUTH, AND T. SHENK. Adenovirus terminal protein mediates both nuclear-matrix association and efficient transcription of adenovirus DNA. Genes Dev. 4:1197-1208, 1990.
352. SCHEDLICH, L. J., J. L. FLANAGAN, L. A. CROFTS, S. A. GILLIES, D. GOLDBERG, N. A. MORRISON, AND J. A. EISMAN. Transcriptional activation of the human osteoealcin gene by basic fibroblast growth factor. J. Bone Miner. Res. 9: 143-152, 1994.
353. SCHEPMOES, G., E. BREEN, T. A. OWEN, M. A. ARONOW, G. S. STEIN, AND J. B. LIAN. Influence of dexamethasone on the vitamin D-mediated regulation of osteocalcin gene expression. J. Cell. Biochem. 47: 184-196, 1991.
354. SCHOETERS, G. E. R., L. DE SAINT-GEORGES, R. VAN DEN HEUVEL, AND O. VANDERBORGHT. Mineralization of adult mouse bone marrow in vitro. Cell Tissue Kinet. 21: 363-374, 1988.
355. SCHRADER, M., I. BENDIK, M. BECKER-ANDRE, AND C. CARLBERG. Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem. 268: 17830-17836, 1993.
356. SCHRÖDER, H. C., D. TRÖLLTSCH, U. FRIESE, M. BACHMANN, AND W. E. G. MÜLLER. Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J. Biol. Chem. 262: 8917-8925, 1987.
357. SCHRÖDER, H. C., D. TRÖLLTSCH, R. WENGER, M. BACHMANN, B. DIEHL-SEIFERT, AND W. E. G. MÜLLER. Cytochalasin B selectively releases ovalbumin mRNA precursors but not the mature ovalbumin mRNA from hen oviduct nuclear matrix. Eur. J. Biochem. 167: 239-245, 1987.
358. SCHUBART, U. K., J. XU, W. FAN, G. CHENG, H. GOLDSTEIN, G. ALPINI, D. A. SHAFRITZ, J. A. AMAT, M. FAROOQ, W. T. NORTON, T. A. OWEN, J. B. LIAN, AND G. S. STEIN. Widespread differentiation stage-specific expression of the gene encoding phosphoprotein p!9 (metablastin) in mammalian cells. Differentiation 51: 21-32, 1992.
359. SCULE, R., K UMESONO, D. J. MANGELSDORF, J. BOLADO, J. W. PIKE, AND R. M. EVANS. Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61: 497-504, 1990.
360. SERRANO, M., G. J. HANNON, AND D. BEACH. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4. Nature Lond. 366: 704-707, 1993.
361. SHAKOORI, A. R., A. M. OBERDORF, T. A. OWEN, L. A. WEBER, E. HICKEY, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Expression of heat shock genes during differentiation of mammalian osteoblasts and promyelocytic leukemia cells. J. Cell. Biochem. 48: 277-287, 1992.
362. SHAKOORI, A. R., T. A. OWEN, V. SHALHOUB, J. L. STEIN, M. BUSTIN, G. S. STEIN, AND J. B. LIAN. Differential expression of the chromosomal high mobility group proteins 14 and 17 during the onset of differentiation in mammalian osteoblasts and promyelocytic leukemia cells. J. Cell. Biochem. 51: 479-487, 1993.
363. SHAKOORI, A. R., A. J. VAN WIJNEN, R. BORTELL, T. A. OWEN, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Variations in vitamin D receptor transcription factor complexes associated with the bone-specific osteoealcin gene vitamin D responsive element in osteoblasts and osteosarcoma cells. J. Cell. Biochem. 55: 1-12, 1994.
364. SHAKOORI, R., A. J. VAN WIJNEN, C. COOPER, F. AZIZ, M. BIRNBAUM, G. P. V. REDDY, A. DE LUCA, X. GRANA, A. GIORDANO, J. B LIAN, J. L. STEIN, P. QUESENBERRY, AND G. S. STEIN. Cytokine-induction of proliferation and expression of cde2 and cyclin A in FDCP-1 myeloid hematopoietic progenitor cells: regulation of ubiquitous and cell cycle dependent histone gene transcription factors. J. Cell. Biochem. 59: 291-302, 1995.
365. SHALHOUB, V., R. BORTELL, M. E. JACKSON, S. C. MARKS, JR., J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Transcriptionally active nuclei isolated from intact bone reflect modified levels of gene expression in skeletal development and pathology. J. Cell Biochem. 55: 182-189, 1994.
366. SHALHOUB, V., C CONLON, M. TASSINARI. C. QUINN. N PARTRIDGE, G. S. STEIN, AND J. B. LIAN. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J. Cell. Biochem. 50: 425-440, 1992.
367. SHALHOUB, V., L. C. GERSTENFELD, D. COLLART, J. B. LIAN, AND G. S. STEIN. Downregulation of cell growth and cell cycle regulated genes during chick osteoblast differentiation with the reciprocal expression of histone gene variants. Biochemistry 28: 5318-5322, 1989.
368. SHALHOUB, V., M. E. JACKSON, J. B. LIAN, G. S. STEIN, AND S. C. MARKS, JR. Gene expression during skeletal development in three osteopetrotic rat mutations: evidence for osteoblast abnormalities. J. Biol. Chem. 266: 9847-9856, 1991.
369. SHARMA, A., T. J. BOS, A. PEKKALA-FLAGAN, P. K. VOGT, AND A. S. LEE. Interaction of cellular factors related to the Jun oncoprotein with the promoter of a replication-dependent hamster histone H3-2 gene. Proc. Natl. Acad. Sci. USA 86: 491-495, 1989.
370. SHARMA, A., A. S. LEE, AND R. MAXSON. Cell cycle regulation of H2b histone octamer DNA binding activity in Chinese hamster lung fibroblasts. MoL Cell. Biol. 9: 869-873, 1989.
371. SHERLEY, J. L., AND T. J. KELLY. Regulation of human thymidine kinase during the cell cycle. J. Biol. Chem. 263: 8350-8358, 1988.
372. SHEER, C. J. Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
373. SHEER, C. J. G1 phase progression: cycling on cue. Cell 79: 551-555, 1994.
374. SIDDHANTI, S. R., AND L. D. QUARLES. Molecular to pharmacologic control of osteoblast proliferation and differentiation. J. Cell. Biochem. 55: 310-320, 1994.
375. SIERRA, F., G. STEIN, AND J. STEIN. Structure and in vitro transcription of a human H4 histone gene. Nucleic Acids Res. 11: 7069-7086, 1983.
376. SIMEONE, A., D. ACAMPORA, M. PANNESE, M. D'ESPOSITO, A. STORNAIUOLO, M. GULISANO, A. MALLAMACI, K. KASTURY, T. DRUCK, K. HUEBNER, AND E. BONCINELLI. Cloning and characterization of two new members of the vertebrate Dlx family. Proc. Natl. Acad. Sci. USA 91: 2250-2254, 1994.
377. SONE, T., K. OZONO, AND J. W. PIKE. A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol. Endocrinol. 5: 1578-1586, 1991.
378. 3 action in osteoblast-like cells. Bone Miner. 26: 27-42, 1994.
379. STAUBER, C., B. LUSCHER, R. ECKNER, E. LOTSCHER, AND D. SCHUMPERLI. A signal regulating mouse H4 mRNA levels in a mammalian cell cycle mutant and sequences controlling RNA 3′ processing are both contained within the same 80 bp fragment. EMBO J. 5: 3297-3303, 1986.
380. STEIN, G. S., AND T. W. BORUN. The synthesis of acidic chromosomal proteins during the cell cycle of HeLa S3 cells. I. The accelerated accumulation of acidic residual nuclear protein before the initiation of DNA replication. J. Cell Biol. 52: 292-307, 1972.
381. STEIN, G. S., AND J. B. LIAN (Editors). Molecular and Cellular Approaches to the Control of Proliferation and Differentiation. Orlando, FL: Academic, 1992.
382. STEIN, G. S., AND J. B. LIAN Molecular mechanisms mediating developmental and hormone regulated expression of genes in osteoblasts: an integrated relationship of cell growth and differentiation. In: Cellular and Molecular Biology of Bone, edited by M. Noda. Orlando, FL: Academic, 1993, p. 47-95.
383. STEIN, G. S., AND J. B. LIAN. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14: 424-442, 1993.
384. STEIN, G. S., J. B. LIAN, S. I. DWORETZKY, T. A. OWEN, R. BORTELL, J. P. BIDWELL, AND A. J. VAN WIJNEN. Regulation of transcription-factor activity during growth and differentiation: involvement of the nuclear matrix in concentration and localization of promoter binding proteins J. Cell. Biochem. 47: 300-305, 1991.
385. STEIN, G. S., J. B. LIAN, AND T A. OWEN. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 4: 3111-3123, 1990.
386. STEIN, G. S., J. B. LIAN, T. A. OWEN, J. HOLTHUIS, R. BORTELL, AND A. J. VAN WIJNEN. Molecular mechanisms that mediate a functional relationship between proliferation and differentiation. In: Molecular and Cellular Approaches to the Control of Proliferation and Differentiation, edited by G. S. Stein and J. B. Lian. Orlando, FL: Academic, 1992, p. 299-341.
387. STEIN, G. S., J. B. UAN, J. L. STEIN, R. BRIGGS, V. SHALHOUB, K. WRIGHT, U. PAULI, AND A. VAN WIJNEN. Altered binding of human histone gene transcription factors during the shutdown of proliferation and onset of differentiation in HL-60 cells. Proc. Natl. Acad. Sci. USA 86: 1865-1869, 1989.
388. 3 and vitamin D analogs on developmental control of cell growth and tissue-specific gene expression during osteoblast differentiation. Biomed. Chem. Lett. 3: 1885-1891, 1993.
389. STEIN, G. S., W. D. PARK, C. L. THRALL, R. J. MANS, AND J. L. STEIN. Regulation of cell cycle stage-specific transcription of histone genes from chromatin by nonhistone chromosomal proteins. Nature Lond. 257: 764-767, 1975.
390. STEIN, G. S., AND J. L. STEIN. The relationship between human histone gene expression and DNA replication. Bioessays 1: 202-205, 1984.
391. STEIN, G. S., J. L. STEIN, AND W. F. MARZLUFF. Histone Genes. New York: Wiley, 1984.
392. STEIN, G. S., J. L. STEIN, A. J. VAN WIJNEN, AND J. B. LIAN. Histone gene transcription: a model for responsiveness to an integrated series of regulatory signals mediating cell cycle control and proliferation/differentiation interrelationships. J. Cell. Biochem. 54: 393-404, 1994.
393. STIEF, A., D. M. WINTER, W. H. STRATUNG, AND A. E. SIPPEL. A nuclear attachment element mediates elevated and position-independent gene activity. Nature Lond. 341: 343-345, 1989.
394. 3 receptor in vivo. Proc. Natl. Acad. Sci. USA 86: 9770-9773, 1989.
395. STROMSTEDT, P. E., L. POELLINGER, J. A. GUSTAFSSON, AND J. CRALSTEDT-DUKE. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter, a potential mechanism for negative regulation. Mol. Cell. Biol. 11:3379-3383, 1991.
396. SUBRAMANIAM, M., D. COLVARD, P. E. KEETING, K. RASMUSSEN, B. L. RIGGS, AND T. C. SPELSBERG. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-hke cells. J. Cell. Biochem 50: 411-424, 1992.
397. SUDA, T., N. TAKAHASHI, AND A. ETSUKO. Role of vitamin D in bone resorption. J. Cell. Biochem. 49: 53-58, 1992.
398. TABIN, C. J. Retinoids, homeoboxes, and growth factors: towards molecular models for limb development. Cell 66: 199-217, 1991.
399. TAICHMAN, R. S., AND P. V. HAUSCHKA, Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteoblastic expression of osteocalcin and mineralized extracellular matrix in vitro. J. Inflammation 16: 587-601, 1992.
400. TAMURA, M., AND M. NODA. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J. Cell Biol. 126: 773-782, 1994.
401. TANAKA, N., M. ISHIHARA, M. KITAGAWA, H. HARADA, T. KIMURA, T. MATSUYAMA, M. S. LAMPHLER, S. AIZAWA, T. W. MAK, AND T. TAMGUCHI. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77: 829-839, 1994.
402. TASSINARI, M. S., L. C. GERSTENFELD, G. S. STEIN, AND J. B. LIAN. Effect of caffeine on parameters of osteoblast growth and the differentiation of a mineralized extracellular matrix in vitro. J. Bone Miner. Res. 6: 1029-1036, 1991.
403. TAWFIC, S., AND K. AHMED. Growth stimulus-mediated differential translocation of casein kinase 2 to the nuclear matrix. J. Biol. Chem. 269: 24615-24620, 1994.
404. TENHARMSEL, A., R. J. AUSTIN, N. SAVENELLI, AND M. D. BIGGIN. Cooperative binding at a distance by even-skipped protein correlates with repression and suggests a mechanism of silencing. Mol. Cell. Biol. 13: 2742-2752, 1993.
405. 3-mediated transcriptional activation. Mol. Endocrinol. 5: 373-385, 1991.
406. THIEDE, M. A., S. L. SMOCK, D. N. PETERSEN, W. A. GRASSER, D. D. THOMPSON, AND S. K. NISHIMOTO. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135: 929-935, 1994.
407. THORBURN, A., R. MOORE, AND J. KNOWLAND. Attachment of transcriptionally active sequences to the nucleoskeleton under isotonic conditions (Abstract). Nucleic Acids Res. 16: 7183, 1988.
408. 3 receptor mechanism of dimer binding to an asymmetric repeat element. Proc. Natl. Acad. Sci. USA 90: 6310-6314, 1993.
409. TOWLER, D. A., C. D. BENNETT, AND G. A. RODAN. Activity of the rat osteocaicin basal promoter in osteoblastic cells is dependent upon homeodomain and CP1 binding motifs. Mol. Endocrinol. 8: 614-624, 1994.
410. TOWLER, D. A., AND G. A. RODAN. Cross-talk between glucocorticoid and PTH signaling in the regulation of the rat osteocalcin promoter. J. Bone Miner. Res. 9, Suppl.: S282, 1994.
411. TOWLER, D. A., S. J. RUTLEDGE, AND G. A. RODAN. Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocaicin promoter. Mol. Endocrinol 8: 1484-1493, 1994.
412. TRUSS, M , AND M. BEATO. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14: 459-479, 1993.
413. TURKSON, K., AND J. E. AUBIN. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J. Cell Biol. 114: 373-384, 1991.
414. 3 receptors. Cell 65: 1255-1266, 1991.
415. VAISHNAV, R., J. N. BERESFORD, J. A. GAULAGHER, AND R. G. G. RUSSELL. Effects of the anabolic steroid stanozolol on cells derived from human bone. Clin. Sci. 74: 455-460, 1988.
416. VAN BEEK, E., L. VAN DER WEE-PALS, M. VAN DE RUIT, P NIJWEIDE, S. PAPAPOULOS, AND C. LOWIK Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture. J. Bone Miner. Res. 8: 191-198, 1993.
417. VAN DEN ENT, F. M. I., A. J. VAN WIJNEN, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Cell cycle controlled histone H1, H3 and H4 genes share unusual arrangements of recognition motifs for HiNF-D supporting a coordinate promoter binding mechanism. J. Cell. Physiol 159: 515-530, 1994.
418. VAN DEN ENT, F. M. I., A. J. VAN WIJNEN, T. J. LAST, R. BORTELL, J. L. STEIN, J. B. LIAN, AND G. S. STEIN. Concerted control of multiple histone promoter factors during cell density inhibition of proliferation in osteosarcoma cells: reciprocal regulation of cell cycle controlled and bone-related genes. Cancer Res. 53: 2399-2409, 1993.
419. VAN DER HOUVEN VAN OORDT, C. W., A. J. VAN WIJNEN, R. CARTER, K. SOPRANO, J. B. LIAN, G. S. STEIN, AND J. L. STEIN. Protein-DNA interactions at the H4-site III upstream transcriptional element of a cell cycle regulated histone H4 gene: differences in normal versus tumor cells. J. Cell. Biochem. 49: 93-110, 1991.
420. VAN DER PLAS, A., AND P. J. NIJWEIDE. Isolation and purification of osteocytes. J. Bone Miner. Res. 7: 389-396, 1992.
421. VAN EEKLEN, C. A. G., AND W. J. VAN VENROOIJ. hnRNA and its attachment to a nuclear-protein matrix. J. Cell Biol. 88: 554-563, 1981.
422. 3 receptor in osteoblast-like cells. J. Biol. Chem. 270: 165-167, 1990.
423. VAN WIJNEN, A. J., F. AZIZ, X. GRANA, A. DE LUCA, R. K. DESAI, K JAARSVELD, T. J. LAST, K. SOPRANO, A. GIORDANO, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Transcription of histone H4, H3 and H1 cell cycle genes: promoter factor HiNF-D contains CDC2, cyclin A and an RB-related protein. Proc. Natl. Acad. Sci. USA 91: 12882-12886, 1994.
424. VAN WIJNEN, A. J., J. P. BIDWELL, E. G. FEY, S. PENMAN, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Nuclear matrix association of multiple sequence specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1 and AP-1. Biochemistry 32: 8397-8402, 1993.
425. VAN WIJNEN, A. J., T. K. CHOI, T. A. OWEN, K. L WRIGHT, J. B. LIAN, R. JAENISCH, J. L. STEIN, AND G. S. STEIN. Involvement of the cell cycle-regulated nuclear factor HiNF-D in cell-growth control of a human H4 histone gene during hepatic development in transgenic mice. Proc. Natl. Acad. Sci. USA 88: 2573-2577, 1991.
426. VAN WIJNEN, A. J., J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Protein/DNA interactions involving ATF/AP1-, CCAAT-, and HiNF-D-related factors in the human H3-ST519 histone promoter cross-competition with transcription regulatory sites in cell cycle controlled H4 and H1 histone genes. J. Cell. Biochem. 47: 337-351, 1991.
427. VAN WIJNEN, A. J., R. F. MASSUNG, J. STEIN, AND G. STEIN. Human H1 histone gene promoter CCAAT-box binding protein HiNF-B is a mosaic factor. Biochemistry 27: 6534-6541, 1988.
428. VAN WIJNEN, A. J., H. MERRIMAN, B. GUO, J. P. BIDWELL, J. L. STEIN, J. LIAN, AND G. STEIN. Nuclear matrix interactions with the osteocalcin gene promoter multiple binding sites for the runthomology related protein NMP-2 and for NMP-1, a heteromeric creb-2 containing transcription factor. J. Bone Miner. Res. 9, Suppl.: S148, 1994.
429. VAN WIJNEN, A. J., T. A. OWEN, J. HOLTHUIS, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Coordination of protein-DNA interactions in the promoters of human H4, H3, and H1 histone genes during the cell cycle, tumorigenesis and development. J. Cell. Physiol 148: 174-189, 1991.
430. VAN WIJNEN, A. J., A. L. RAMSEY-EWING, R. BORTELL, T. A. OWEN, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Transcriptional element H4-site II of cell cycle regulated human H4 histone genes is a multipartite protein/DNA interaction site for factors HiNF-D, HiNF-M, and HiNF-P: involvement of phosphorylation. J. Cell. Biochem. 46: 174-189, 1991.
431. VAN WIJNEN, A. J., F. M. I. VAN DEN ENT, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Overlapping and CpG methylation-sensitive protein/DNA interactions at the histone H4 transcriptional cell cycle domain: distinctions between two human H4 gene promoters. Mol. Cell. Biol. 12: 3273-3287, 1992.
432. VAN WIJNEN, A. J., K. L. WRIGHT, J. B. LIAN, J. L. STEIN, AND G. S. STEIN. Human H4 histone gene transcription requires the proliferation-specific nuclear factor HiNF-D. J. Biol. Chem. 264: 15034-15042, 1989.
433. VAUGHN, J. P., P. A. DIJKWEL, L. H. F. MULLNDERS, AND J. L. HAMLIN. Replication forks are associated with the nuclear matrix. Nucleic Acids Res. 18: 1965-1969, 1990.
434. VAUGHAN, P. S., F. AZIZ, A. J. VAN WIJNEN, S. WU, K. SOPRANO, G. S. STEIN, AND J. L. STEIN. Activation of a cell cycle regulated histone gene by the oncogenic transcription factor IRF2. Nature Lond. 377: 362-365, 1995.
435. VILAMITJANA-AMEDEE, J., R. BAREILLE, F. ROUAIS, A. I. CAPLAN, AND M.-F. HARMAND. Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev. Biol. 29: 699-707, 1993.
436. VON KKIES, J. P., H. BUHRMESTER, AND W. H. STRATLING. A matrix/scaffold attachment region binding protein: identification, purification and mode of binding. Cell 64: 123-135, 1991.
437. VUKICEVIC, S., F. P. LUYTEN, H. K. KLEINMAN, AND A. H. REDDI. Differentiation of canalicular cell processes in bone cells by basement membrane matrix components: regulation by discrete domains of laminin. Cell 63: 437-445, 1990.
438. VUORIO, E., AND B. DE CROMBRUGGHE. The family of collagen genes. Annu. Rev. Biochem. 59: 837-872, 1990.
439. WALTERS, M. R. Newly identified actions of the vitamin D endocrine system. Endocr. Rev. 13: 719-755, 1992.
440. WEINREB, M., D. SHINAR, AND G. A. RODAN. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J. Bone Miner. Res. 5: 831-842, 1990.
441. WELLS, D..,D. HOFFMAN, AND L. KEDES. Unusual structure, evolutionary conservation of non-coding sequences and numerous pseudogenes characterize the human H3.3 histone multigene family. Nucleic Acids Res. 15: 2871-2889, 1987.
442. WHITSON, S. W., W. HARRISON, M. K. DUNLAP, D. E. BOWERS, JR., L. W. FISHER, P. G. ROBEY, AND J. D. TERMINE. Fetal bovine cells synthesize bone specific matrix proteins. J. Cell Biol. 88: 607-614, 1984.
443. WONG, G. L., AND D. V. COHN. Target cells in bone for parathyroid hormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and adhesion to polymeric surfaces. Proc. Natl. Acad. Sci. USA 72: 3167-3171, 1975.
444. WONG, M. M., L. G. RAO, H. LY, L. HAMILTON, J. TONG, W. STURTRIDGE, R. McBROOM, J. E. AUBIN, AND T. M. MURRAY. Long-term effects of physiologic concentrations of dexamethasone on human bone-derived cells. J. Bone Miner. Res. 5: 803-813, 1990.
445. WRIGHT, K. L., M. J. BIRNBAUM, A. VAN WIJNEN, G. S. STEIN, AND J. L. STEIN. Bipartite structure of the proximal promoter of a human histone gene. J. Cell. Biochem. 58: 372-379, 1995.
446. WRIGHT, K. L., R. T. DELLORCO, A. J. VAN WIJNEN, J. L. STEIN, AND G. S. STEIN. Multiple mechanisms regulate the proliferation specific histone gene transcription factor, HiNF-D, in normal human diploid flbroblasts. Biochemistry 31: 2812-2818, 1992.
447. XING, Y., C. V. JOHNSON, P. R. DOBNER, AND J. B. LAWRENCE. Higher level organization of individual gene transcription and RNA splicing. Science Wash. DC 259: 1326-1330, 1993.
448. XIONG, Y., H ZHANG, AND D. BEACH. D type cyclins associate with multiple protein kinases and the DNA replication factor PCNA. Cell 71: 505-514, 1992.
449. YANG, J.-Q., E. F. REMMERS, AND K. B. MARCU. The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J. 5: 3553-3562, 1986.
450. YAO, K. L., R. TODESCAN, AND J. SODEK. Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J. Bone Miner. Res. 9: 231-240, 1994.
451. YOON, K., R. BUENAGA, AND G. A. RODAN. Tissue specificity and developmental expression of osteopontin. Biochem. Biophys. Res. Commun. 148: 1129-1136, 1987.
452. 3. Biochemistry 17: 8521-8526, 1988.
453. YOUNG, M. F., J. M. KERR, K. IBARAKI, A.-M. HEEGAARD, AND P. GEHRON-ROBEY. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin. Orthoped, Relat, Res. 281: 275-294, 1992.
454. YU, V. C., C. DELSERT, B. ANDERSEN, J. M. HOLLOWAY, O. V. DEVRAY, A. M. NAAR, S. Y. KIM, J. M. BOUTIN, C. K. GLASS, AND M. G. ROSENFELD. RXRβ: a coregulator that enhances binding of retinoic acid thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991.
455. ZAMBETTI, G., R. QUARTIN, J. MARTINEZ, I. GEORGOFF, J. MOMAND, D. DITTMER, C. FINLAY, AND A. LEVINE. Regulation of transformation and the cell cycle by p53. Cold Spring Harbor Symp. Quant. Biol. 56: 219-225, 1991.
456. ZAMBETTI, G., J. L. STEIN, AND G. S. STEIN. Targeting of a chimeric human histone fusion mRNA to membrane-bound polysomes in HeLa cells. Proc. Natl. Acad. Sci. USA 84: 2683-2687, 1987.
457. ZAMBETTI, G., J. L. STEIN, AND G. S. STEIN. Role of messenger RNA subcellular localization in the post-transcriptional regulation of human histone gene expression. J. Cell. Physiol. 144: 175-182, 1990.
458. ZEITLIN, S., A. PARENT, S. SILVERSTEIN, AND A. EFSTRATIADIS. Pre-mRNA splicing and the nuclear matrix. Mol. Cell. Biol. 7: 111-120, 1987.
459. ZENK, D. W., G. D. GINDER, AND T. W. BROTHERTON. A nuclearmatrix protein binds very tightly to DNA in the avian β-globin gene enhancer. Biochemistry 29: 5221-5226, 1990.
460. ZERNIK, J., M. A. THIEDE, K. TWAROG, M. L STOVER, G. A. RODAN, W. B. UPHOLT, AND D. W. ROWE. Cloning and analysis of the 5′ region of the rat bone/liver/kidney/placenta alkaline phosphatase gene. A dual-function promoter. Matrix 10: 38-47, 1990.
461. 3) 24-hydroxylase gene. Proc. Natl. Acad. Sci. USA 91:900-902, 1994.